Days of life in medicine

 

 

  I've learnt a couple of  life saving procedural skills during my residency program which would help me further in evaluating and save the life of patients, among which some of the nameful skills are performing intubations, 2dechos, usg abdomen and also I've placed a number of central venous lines both for femoral and IJV since the number of visiting CKD patients are more at our rural heath set up. I've also perfomed a couple of lumbar punctures along with pleural taps, ascitic tap along with pericardiocentesis ,Lung biopsy, Liver Biopsy LUNG BIOPSY: LUMBAR PUNCTURE: 2ECHO OF A MYXEDEMA COMA PATIENT WITH PERICARDIAL EFFUSION ADMITTED WITH US ANKLE JERK IN 15 YEAR OLD BOY WITH PARAPARESIS KNEE JERK IN 15 YEAR OLD BOY WITH PARAPARESIS FEMORAL CENTRAL LINE PLACEMENT IJV LINE PLACEMENT DEMONSTRATION OF DEEP TENDON REFLEXES TO MY JUNIORS INVERSION OF BICEPS

A 35 year old man, working at a store for printing wedding cards, from Suryapet presented to the casualty at 8pm with the  complaints of  Fever since 2 months Generalized weakness since 2 months  Dyspnea on exertion since 2 months  Pain abdomen since 20 days Right sided chest pain since 20 days Vomiting since 20 days  Dark coloured stools since 20 days He works at a store that prints wedding cards at Suryapet. He has 2 daughters. Since the past 15 years he has been consuming alcohol everyday, he consumes around 360ml of whiskey per day and his last alcohol intake was yesterday. Since 15 years he has been smoking, he says he only smokes occasionally.  Since the past 2 years he started to experience  loss of appetite. He also tells us that he started consuming less food and started to consume larger amounts of alcohol. He also tells us that he started to experience recurrent episodes of pain abdomen along with recurrent episodes of vomiting every alternate day and he has visited hospital

  The different medical complications observed in a rural medical hospital from  excessive alcohol indulgence and the importance of alcohol abstinence Abstract: Introduction: Alcohol consumption has been identified as an important risk factor for illness, disability, and mortality (Rehm et al. 2009 b ). In this study we discuss the various medical conditions we've come across at a rural medical hospital caused by alcohol and conditions where in alcohol plays a role of a contributing factor and the importance of alcohol abstinence. Materials and methods: This is a prospective study conducted at Kamineni Insitute of Medical Scineces, Narketpally including 70 inpatients after taking their informed consent. Results: The most common disease categories observed during this study entirely or partly caused by alcohol consumption were  liver and pancreatic diseases (49%), neuropsychiatric diseases ( 31%), cardiovascular diseases(13%), diabetes (4%), 3% presenting with multiorgan dys

I've conducted a retrospective study on covid 19 patients evaluating their clinical course and risk factors for mortality. The following is the abstract of the paper I'm currently working on. A retrospective analysis of the clinical course and the risk factors for mortality in covid 19 patients in a rural health center Abstract: Introduction: In December, 2019, Wuhan city, China, became the centre of an outbreak for pneumonia of unknown cause. By January, 2020, Chinese scientists had isolated a novel coronavirus, severe acute respiratory syndrome coronavirus, from these patients with virus-infected pneumonia, which was later designated coronavirus disease 2019 (COVID-19) in February, 2020, by WHO. In this study we discuss the various clinical presentations and the risk factors for mortality observed in  covid 19 patients. Materials and methods: This is a retrospective study conducted at Kamineni Insitute of Medical Scineces, Narketpally including 34 inpatients who were te

In reference to the patient mentioned in the blog here 👇 http://gm-elogbook-anudeep-98.blogspot.com/2021/11/30yr-old-male-with-urinary-retention.html To perform a prospective, placebo-controlled study to examine the long-term efficacy of alfuzosin compared with placebo and standard therapy in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) P - One hundred twenty consecutive men diagnosed with CP/CPPS I - 17 in the alfuzosin C - 20 in the placebo 29 in the control/standard group O -  At the end of 6 months of active therapy, the alfuzosin group had had a statistically significant decrease in total NIH-CPSI score compared with the placebo and control/standard groups (9.9, 3.8, and 4.3 decrease, respectively, P = 0.01). A statistically significant improvement occurred in the pain score in the alfuzosin group at 6 months compared with the placebo and control/standard groups (P = 0.01), but not in the voiding or quality-of-life score among the three groups. Of the